Publications by authors named "Slawomir Garbicz"
Background: Improvement of the delivery method of inhaled corticosteroids and subsequent dose reduction can minimize the risk of unfavorable outcomes while providing optimal asthma control.
Objective: This randomized, multi-center, non-inferiority, phase IV clinical study compared the efficacy and safety of a new formulation of fluticasone propionate/salmeterol (250 μg/50 μg, twice daily) administered in a metered-dose inhaler hydrofluoroalkane (MDI HFA) with a dry-powder inhaler (DPI) containing fluticasone propionate/salmeterol (500 μg/50 μg, twice daily).
Methods: Adults with asthma (n = 231) were randomly assigned to either the study group (treated for 12 weeks with fluticasone propionate/salmeterol MDI HFA) or a control group (treated for 12 weeks with fluticasone propionate/salmeterol DPI).
Article Synopsis
- Pulmonary actinomycosis is a rare lung disease caused by the bacteria Actinomyces, making diagnosis challenging due to non-specific symptoms and imaging results.
- A case study details a 59-year-old man whose condition stemmed from poor dental hygiene, leading to lung and chest wall infections with osteolysis and skin fistulas.
- Diagnosis was confirmed through histopathological analysis of samples from the fistulas, showing Actinomyces, and after six months of antibiotics, the patient improved and experienced healing of skin lesions and partial lung recovery.